All patients with CD with ileal disease in clinical remission (n = 5) showed high apical DPP-4/CD26 expression, in contrast to 29% of the patients with CD with clinical activity (n = 7) (Figure 3 , 2B and 2C); nevertheless, these differences did not reach statistical significance ( P = 0.190).
← all excerpts
Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel Disease.
1
0.1900
0.1900